- Listing of analysis and detail
- Result reference range
-
Genetic Testing for Hereditary Cancer
- Request Form
- Informed Consent
- Sample Report
- Appendix
-
Research Papers
- Direct Sequencing and Characterization of a Clinical Isolate of Epstein-Barr Virus from Nasopharyngeal Carcinoma Tissue by Using Next-Generation Sequencing Technology
- Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
- Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor
- Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma
-
Essential documents for NIFTY test
- Request form
- Information and Consent
- Sample report
- Sample report(For twin pregnancy)
- Brochure
- Introduction of disease and detection method for NIFTY test
-
Research papers
- Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study
- Clinical utility of Non-Invasive Fetal Trisomy(NIFTY) test – Early experience
- DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study
- Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing
- Non-invasive Prenatal Genetic Testing of Fetal Chromosomal Aneuploidy
- Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing
- Prenatal Detection of Aneuploidy and Imbalanced Chromosomal Arrangements by Massively Parallel Sequencing
- Presence of fetal DNA in maternal plasma and serum
- Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis
- Quantification of Fetal DNA by Use of Methylation-Based DNA Discriminaton
- FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma
- Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks’ gestation: relation to maternal and fetal characteristics
- NIFTY’s ability in del/dup detection
- 1Non-Twin-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies
- Effective Noninvasive Zygosity Determination by Maternal Plasma Target Region Sequencing
- A method for noninvasive detection of fetal large deletions duplications by low coverage massively parallel sequencing
- Comparative information on NIFTY and cell free fetal DNA with SNP method
- Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4,736 pregnancies
-
Newborn Genetic testing for Hearing Impairment
-
Newborn Metabolic Disorders
-
Whole Exome Sequencing
-
Sequencing Service
-
Pre-eclampsia
-
Newborn Metabolic Screening
